Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study
Open Access
- 1 September 2005
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 116 (3), e334-e342
- https://doi.org/10.1542/peds.2004-2638
Abstract
Objective. This study was designed to compare the safety and efficacy of tacrolimus ointment 0.03% with vehicle ointment for the treatment of mild to moderate atopic dermatitis (AD) in pediatric patients.Keywords
This publication has 28 references indexed in Scilit:
- Effects of Atopic Dermatitis on Young American Children and Their FamiliesPediatrics, 2004
- Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitisBritish Journal of Dermatology, 2004
- 0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trialBritish Journal of Dermatology, 2004
- Guidelines of care for atopic dermatitisJournal of the American Academy of Dermatology, 2004
- Letters to the Editors: 1Clinical Endocrinology, 2003
- Cost of Illness of Atopic Dermatitis in ChildrenPharmacoEconomics, 2003
- Are quality of family life and disease severity related in childhood atopic dermatitis?Journal of the European Academy of Dermatology and Venereology, 2002
- Atopic eczema: its impact on the family and financial costArchives of Disease in Childhood, 1997
- Bone mineral density in patients with atopic dermatitisBritish Journal of Dermatology, 1997
- Increased Vasoconstrictor Sensitivity to Glucocorticoids in Essential HypertensionHypertension, 1996